Vincent Shier

Vincent K Shier PhD is a partner in the Intellectual Property Practice Group in Haynes Boone’s Washington DC office. He holds a doctorate in biological chemistry and has practiced IP law for more than two decades, preparing and prosecuting patent applications, counseling clients in strategic IP considerations, IP due diligence and representing clients in post-grant proceedings at the US Patent and Trademark Office (USPTO). Another aspect of Vince’s work involves working with venture capital firms, private equity portfolio companies, startup biotechnology companies, and small-mid cap biotechnology and pharmaceutical companies. In this capacity, Vince advises venture capital firms on investable technologies and identification of complementary IP for in-licensing, as well as building developing strategies for portfolio companies to strategically align the development of patent portfolios with company growth and objectives. Drawing from his cross-disciplinary education, Vince’s practice focuses on representing clients in the biotechnology, life sciences, and pharmaceutical fields, as well as many chemical disciplines. These technologies include genetics, molecular biology, therapeutic methods, pharmaceuticals, DNA microarray technology, protein engineering, diagnostics, plants, FoodTech including alternate protein and cultivated meats, AgriTech, renewable energies, batteries, plastics, surface materials, minerals and mineral applications, along with an array of other chemical products and processes. Vince has also served as an adjunct professor of law at the Antonin Scalia Law School at George Mason University from 2019 to 2021 teaching introductory patent law courses as well as courses on patent and know-how licensing.

---

Presentation

Panel Discussion